Content reflects the views of the posting party and is provided for informational purposes only. It does not constitute a solicitation, recommendation, endorsement, or investment advice by BioTech Funding Portal.  All content is subject to the portal’s Community Content Guidelines.

 


What's New in Glafabra's Testing the Waters Campaign

Glafabra
Posted at Aug 7

One month into Testing the Waters. Here's what's changing for month two.

More real faces. Starting this Tuesday, we're introducing you to the people building Glafabra — one team member at a time, starting with our CEO.

DECODE keeps going, but simpler: no more separate answer-comment days later. Each new riddle now opens with last time's answer, right in the post.

And more of Glafabra's actual stor...more

Categories: Advanced Therapeutics  |  Cell & Gene Therapy  |  Clinical Research  |  Drug Development  |  Fabry Disease  |  Rare Disease
Tags:

How Is Fabry Disease Inherited? — DECODE No. 10

Glafabra
Posted at Aug 6

(Answer to the question last time on August 3: Pompe disease and Gaucher disease — the same Live-cel platform, one gene swapped in, reaches both.)

Fabry disease runs in families, but not the way most genetic conditions do. One chromosome carries the whole story — and it changes who's affected depending on whether it's inherited from mom or dad.

What inheritance pattern is this? Drop your guess in ...more

Categories: Cell & Gene Therapy  |  Fabry Disease  |  Rare Disease
Tags:

The One Cell Behind Every Live-cel Treatment — DECODE No. 7

Glafabra
Posted at Jul 27

(Last time: gentle outpatient conditioning with melphalan.)

 

Every Live-cel treatment starts with a rare cell harvested from the patient — one that can rebuild the entire blood system and carry a corrected gene to the body for years. Scientists find it by a marker on its surface: a protein tag written as "CD" followed by a number.

 

Which cell — and which number? Drop your guess in the ...more

Categories: Cell & Gene Therapy
Tags:

How Did Gene Therapy Patients Go Home the Same Day? — DECODE No. 6

Glafabra
Posted at Jul 23

(Last time: lentiviral vectors, and why Live-cel can be re-dosed.)

 

Older cell-based gene therapies required hospital admission and weeks of recovery — a barrier so heavy many patients and doctors said no. In the FACTS trial, four of five patients did this same step and went home the same day.

 

What gentler approach made same-day discharge possible? Drop your guess in the comments belo...more

Categories: Cell & Gene Therapy
Tags:

Why Can Some Gene Therapies Be Re-Dosed and Others Can't? — DECODE No. 5

Glafabra
Posted at Jul 20

(Last time: the biweekly ERT infusion schedule.)

 

Some gene therapies can only be given once — the immune system slams the door on a second dose. Live-cel can be given again when it's needed. The difference comes down to what carries the gene into the cell.

 

What kind of delivery system lets Live-cel be re-dosed? Drop your guess in the comments below.

 

Follow the whole series: ht...more

Categories: Cell & Gene Therapy
Tags:

How Can Fixing a Few Cells Treat the Whole Body? — DECODE No. 3

Glafabra
Posted at Jul 13

(Last time: lyso-Gb3, the biomarker that tracks Fabry disease.)

 

Here's a beautiful shortcut in biology: to treat the whole body, you don't have to fix every cell. Fix some, and they secrete a helper the neighboring cells absorb and put to work — spreading the benefit outward.

 

There's a two-word name for this generous phenomenon. What is it? Drop your guess in the comments below.

&nbs...more

Categories: Cell & Gene Therapy
Tags:
  • 1